ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 114346 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 114346; 2) Community: the network communities that were significantly associated with the response to NSC 114346; 3) Molecule: the relationships between components within communities and NSC 114346; 4) MDR: the compounds that were significantly associated with the NSC 114346.

NSC Compound Enrichment Correlation
NSC 107043 Null 0.0137891122538509 0.4463491
NSC 133118 2H-1,2,3-Triazolo[4,5-d]pyrimidin-7-amine, 2-.beta.-D-ribofuranosyl- (9CI) 0.013789112253851 0.22382033
NSC 144163 Quinoxaline, 6-chloro-2,3-bis(iodomethyl)- 0.013789112253851 0.4825128
NSC 175493 Iron, carbonyl(.eta.(5)-2,4-cyclopentadien-1-yl)(dimethylcarbamodithioato-S,S')- 0.013789112253851 0.43842084
NSC 176328 Ellipticine, 6-(3-aminopropyl)-, dihydrochloride 0.013789112253851 0.30461943
NSC 287069 Epicorazine A 0.013789112253851 0.37191171
NSC 330507 Tanespimycin 0.013789112253851 0.43800226
NSC 374980 Acetamide, N-[2,3-bis(acetyloxy)-5,6,7,9-tetrahydro-1-methoxy-10-(methylthio)-9-oxobenzo[a]heptalen-7-yl]-, (S)- 0.013789112253851 0.44312591
NSC 48526 Null 0.013789112253851 0.14460474
NSC 603084 2-Butene, 2,3-dibromo-1,4-bis[(3,4-dichloro-2,5-dihydro- 2-oxofuran-5-yl)oxy]-, (E)- 0.013789112253851 0.44013585
Total:158  Current:59    [First] [Prev] [Next] [Last]